Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Return on Capital Employed (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Return on Capital Employed for 15 consecutive years, with 0.22% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed rose 44.0% to 0.22% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.22%, a 44.0% increase, with the full-year FY2024 number at 0.05%, up 14.0% from a year prior.
  • Return on Capital Employed was 0.22% for Q3 2025 at Xtant Medical Holdings, up from 0.13% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.22% in Q3 2025 to a low of 0.22% in Q3 2024.
  • A 5-year average of 0.07% and a median of 0.09% in 2022 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: dropped -13bps in 2022, then soared 44bps in 2025.
  • Xtant Medical Holdings' Return on Capital Employed stood at 0.02% in 2021, then plummeted by -584bps to 0.16% in 2022, then grew by 7bps to 0.15% in 2023, then surged by 66bps to 0.05% in 2024, then surged by 529bps to 0.22% in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Return on Capital Employed are 0.22% (Q3 2025), 0.13% (Q2 2025), and 0.02% (Q1 2025).